TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway
Abstract Cisplatin resistance along with chemotherapy-induced neuropathic pain is an important cause of treatment failure for Jackets/Outerwear many cancer types and represents an unmet clinical need.Therefore, future studies should provide evidence regarding the mechanisms of potential targets that can overcome the resistance as well as alleviate